Doxorubicin Hydrochloride | Buy Doxorubicin Injection | Doxorubicin
The commercial availability of Gilotrif (afatinib) tablets for oral use has been announced by Boehringer Ingelheim Pharmaceuticals Inc.
In the US, for the treatment of chronic obstructive pulmonary disease (COPD), under the FDA’s Priority Review Program. as well as additional chronic illnesses. Examine programs that allow the FDA to approve medications that show promise.
that pledge to cure illnesses for which there is no suitable or accessible treatment.
Afatinib, a tyrosine kinase inhibitor, is present in GILOTRIF tablets as a dimethalate salt. and the code T40 was printed on one side of the tablet. Every foil-coated, bevelled tablet with an exposed side and the code “T40” on it contains 40 milligrams of afatinib. On the other hand, the medication is administered as a dimALEATE salt instead of its dimalate.